Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic testing can identify ischemic and nonischemic heart failure

08.11.2004


Researchers at Johns Hopkins have shown that genetic testing can be effectively used to distinguish between heart failure patients who suffer from ischemic or nonischemic forms of the disease. Using groupings or clusters of a patient’s gene expression to compare to a diseased "test" set that identifies the cause of heart failure, the Hopkins team assembled a 90-gene profile to determine which type of heart failure had most likely developed. Results showed the test profile to be highly accurate, with 90 percent specificity.



The findings could, if affirmed and adapted to a standardized and affordable test format, someday aid physicians in the diagnosis of heart failure and help determine which kind of therapy is best to use for the condition. In ischemic heart disease, the patient’s arteries have narrowed and the heart cannot pump normally because blood flow (and thus oxygen) is often restricted to the heart muscle. In nonischemic forms of the disease, the heart cannot pump normally because the heart muscle has often enlarged for other reasons, such as physical deformity or alcohol abuse. Both conditions can lead to cardiac arrest or more gradual heart failure as the muscle weakens over time.

"The gene expression differences between various forms of cardiovascular disease are poorly understood, despite the fact that we know there are major differences in what is happening at the cellular level," said Michelle Kittleson, M.D., cardiology fellow at the Johns Hopkins Heart Institute and lead author of the study to be presented at the American Heart Association’s Scientific Sessions 2004 on Nov. 6, as a finalist for the Samuel A. Levine Young Clinical Investigator Award. "Our study shows that gene expression profiling for heart failure patients is not only possible, but accurate as well. Based on these initial findings, we hope to close the gaps in our understanding of the gene expression patterns underlying heart failure and treatments for the illness. Ultimately, we hope to be able to use genetic profiling to classify patients according to their risk of developing all kinds of heart disease."


To create a gene expression profile, or test, the Hopkins team collected 16 biopsy tissue samples, six from patients with the ischemic form of the disease and 10 from nonischemic cases, all with end-stage heart failure. Most of the test samples came from heart transplant patients at Hopkins in the last 20 years. Using a biostatistical technique called prediction analysis, the researchers identified the 90 genes that best distinguished the two kinds of heart failure. The large number of genes used also improved accuracy of the test.

This gene profile was later validated by testing it against 38 other tissue samples, including 14 provided from the University of Minnesota. These test samples involved tissue from all stages of heart failure, including end-stage, post-LVAD (a type of heart surgery) and biopsy samples from newly diagnosed patients.

"Now that we know we can genetically profile heart patients according to ischemic and nonischemic heart disease, our next step is to develop a test that can be used in a clinical setting," said senior study author and cardiologist Joshua Hare, M.D., a professor of medicine at the Heart Institute. "Ischemic patients need to be monitored more closely in case they develop drug resistance and require surgery to unblock clogged arteries. Knowing which patients to treat and how closely to monitor them could significantly improve how well physicians manage the disease and, consequently, improve health outcomes."

David March | EurekAlert!
Further information:
http://www.jhmi.edu

More articles from Life Sciences:

nachricht Fingerprint' technique spots frog populations at risk from pollution
27.03.2017 | Lancaster University

nachricht Parallel computation provides deeper insight into brain function
27.03.2017 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>